top of page

Case Example

Usage of biologics for Ulcerative Colitis and Crohn’s Disease

< Back

Client Challenge

Client sought UC Strategy’s assistance to understand the use of biologics for treatment of Ulcerative Colitis (UC) and Crohn’s Disease (CD) in India. The research objectives were the following: -
● Review current Ulcerative Colitis and Crohn’s Disease landscapes, including treatment paradigms and options, products currently utilized, and unmet needs
● Understand what the main competitive events are that could be expected within the next 5-7 years, from biosimilars to novel MoAs to reformulations
(and any other potential events mentioned)

Our Approach

The following approach was utilized to gather the required data: -
● A KOL list of 69 clinicians was prepared across 8 cities
● Product description was shared by the client, to help assess market potential
● Primary research was conducted with 15 clinicians via the telephone or in-person visits
- Clinicians in the cities of Bengaluru, New Delhi, Mumbai and Kolkata were visited to gather insights
●Data capture with quantitative inputs and written takeaways of each of the interviews were prepared

Our Impact

The research yielded the following results:-
● Market estimates and growth forecasts of usage of biologics at different lines of treatment for Ulcerative Colitis and Crohn’s Disease
● Forecasted penetration of the biologics intended to be marketed by the client
● Pricing sensitivity analysis taking into account client’s product and competition
● Market evolution and future trends

bottom of page